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Abstract 
Aim: To describe a patient with a giant pigment epithelial detachment (PED) secondary 
to exudative age-related macular degeneration (ARMD) successfully treated with a single 
intravitreal ranibizumab (Lucentis) injection (0.5 mg/0.05 ml).  
Methods: An 89-year-old woman presented with a six-day history of reduced vision and 
distortion in the left eye. Best-corrected visual acuity in that eye was 6/15. Fundoscopy 
revealed a giant PED and exudates temporally to the fovea. Optical coherence 
tomography showed a PED associated with subretinal and intraretinal fluid. Fluorescein 
angiography confirmed the diagnosis of an occult choroidal neovascularization. 
Treatment with intravitreal injections of ranibizumab (Lucentis) was recommended, 
although the increased risk of retinal pigment epithelium (RPE) rip was mentioned.  
Results: Four weeks after the first intravitreal Lucentis injection, the visual acuity in the 
left eye improved to 6/7.5, with a significant improvement of the distortion and a 
complete anatomical resolution of the PED confirmed by optical coherence tomography.  
Conclusion: Giant PED secondary to exudative ARMD can be successfully treated with 
intravitreal ranibizumab, despite the increased risk of RPE rip. To our knowledge, this is 
the first case presenting with complete resolution of PED after a single ranibizumab 
injection. 
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Introduction 
Pigment epithelial detachments (PEDs) associated with choroidal neovascularization 
(CNV) due to exudative age-related macular degeneration (ARMD) have a bad prognosis. 
In the past, such PEDs were treated with laser photocoagulation and photodynamic 
therapy (PDT). More recently, they have been treated with intravitreal anti-vascular 
endothelial growth factor (VEGF) injections alone or in combination with PDT [1, 2]. 
Laser photocoagulation and PDT both yielded disappointing results in terms of visual 
acuity and size of the lesion after the treatment. However, intravitreal bevacizumab 
combined with PDT showed good functional and anatomical results for CNV associated 
with PED due to ARMD, and anti-VEGF intravitreally alone had even better results [3, 4]. 
Case Report 
An 89-year-old woman with ARMD presented with a six-day history of reduced vision and 
distortion in the left eye. Best-corrected visual acuity in this eye was 6/15. Fundoscopy revealed a giant 
PED and exudates temporally to the fovea. Optical coherence tomography (OCT) also showed a giant 
PED with subretinal fluid and intraretinal cysts (fig. 1). Fluorescein angiography demonstrated early 
pooling of the dye suggestive of a PED and late mottled hyperfluorescence compatible with an 
associated occult CNV (fig. 2a, b). 
Treatment with intravitreal injections of ranibizumab (Lucentis) was recommended, although the 
patient was warned about the increased risk of retinal pigment epithelium (RPE) rip. The patient agreed 
and consented for left eye intravitreal ranibizumab (Lucentis) injections. 
The procedure was carried out in the intravitreal suite. Topical proparacaine hydrochloride 0.5% was 
applied to the ocular surface, followed by preparation with 5% povidone iodine. The intravitreal dose of 
ranibizumab (Lucentis) was 0.5 mg/0.05 ml. 
Results 
The patient was reviewed four weeks after the injection. The visual acuity in the left eye 
improved to 6/7.5, with a significant improvement of the distortion. Fundoscopy 
demonstrated some RPE changes and less exudates temporally to the fovea. OCT revealed 
complete anatomical resolution of the PED and disappearance of the subretinal and 
intraretinal fluid (fig. 3). 
Another two intravitreal ranibizumab injections were given to the patient on a four to 
six week basis. Six months after the first presentation, the visual acuity in the left eye was 
unchanged and the condition was stable, without any signs of CNV reactivation or 
recurrence of PED. 
Discussion 
Tears of the RPE may occur in neovascular ARMD, especially in the presence of a PED 
[5]. It is well known that such tears may occur spontaneously or as a complication of a 
laser photocoagulation or a PDT with or without intravitreal triamcinolone or anti-VEGF 
injections [6–9].  
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In our case, a huge PED secondary to exudative ARMD was treated with intravitreal 
ranibizumab, resulting in a complete anatomical resolution of the PED and an 
improvement of the visual acuity and distortion just after a single ranibizumab injection 
of 0.5 mg/0.05 ml. 
To our knowledge, this is the first time such a response is documented by OCT. 
Disclosure Statement 
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Fig. 1. Color fundus photograph and OCT at presentation. 
 
 
 
Fig. 2. Early (a) and late (b) phase of fundus fluorescein angiography at presentation. 
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Fig. 3. Color fundus photograph and OCT four weeks after the first ranibizumab injection. 
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